Reason for request

Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.

-


Clinical Benefit

Insufficient

The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients.

Substantial

Clinical Added Value

no clinical added value

Not applicable


Contact Us

Évaluation des médicaments

See also

All our publications